JPWO2024043334A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2024043334A5
JPWO2024043334A5 JP2024542889A JP2024542889A JPWO2024043334A5 JP WO2024043334 A5 JPWO2024043334 A5 JP WO2024043334A5 JP 2024542889 A JP2024542889 A JP 2024542889A JP 2024542889 A JP2024542889 A JP 2024542889A JP WO2024043334 A5 JPWO2024043334 A5 JP WO2024043334A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
amino
piperazin
ethan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024542889A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2024043334A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/030733 external-priority patent/WO2024043334A1/ja
Publication of JPWO2024043334A1 publication Critical patent/JPWO2024043334A1/ja
Publication of JPWO2024043334A5 publication Critical patent/JPWO2024043334A5/ja
Priority to JP2026046953A priority Critical patent/JP2026098108A/ja
Pending legal-status Critical Current

Links

JP2024542889A 2022-08-26 2023-08-25 Pending JPWO2024043334A1 (cg-RX-API-DMAC7.html)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026046953A JP2026098108A (ja) 2022-08-26 2026-03-23 新規なピペラジン誘導体又はその塩及び医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022135257 2022-08-26
PCT/JP2023/030733 WO2024043334A1 (ja) 2022-08-26 2023-08-25 新規なピペラジン誘導体又はその塩及び医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026046953A Division JP2026098108A (ja) 2022-08-26 2026-03-23 新規なピペラジン誘導体又はその塩及び医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2024043334A1 JPWO2024043334A1 (cg-RX-API-DMAC7.html) 2024-02-29
JPWO2024043334A5 true JPWO2024043334A5 (cg-RX-API-DMAC7.html) 2025-05-09

Family

ID=90013519

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024542889A Pending JPWO2024043334A1 (cg-RX-API-DMAC7.html) 2022-08-26 2023-08-25
JP2026046953A Pending JP2026098108A (ja) 2022-08-26 2026-03-23 新規なピペラジン誘導体又はその塩及び医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026046953A Pending JP2026098108A (ja) 2022-08-26 2026-03-23 新規なピペラジン誘導体又はその塩及び医薬組成物

Country Status (6)

Country Link
US (1) US20250326744A1 (cg-RX-API-DMAC7.html)
EP (1) EP4578849A4 (cg-RX-API-DMAC7.html)
JP (2) JPWO2024043334A1 (cg-RX-API-DMAC7.html)
CN (1) CN119816484A (cg-RX-API-DMAC7.html)
AU (1) AU2023331216A1 (cg-RX-API-DMAC7.html)
WO (1) WO2024043334A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025178125A1 (ja) * 2024-02-22 2025-08-28 富士フイルム株式会社 新規なピペラジン誘導体又はその塩

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09241241A (ja) * 1996-03-08 1997-09-16 Roussel Morishita Kk N−(1−置換−4−ピペリジル)ベンズアミド誘導体
JPWO2002087589A1 (ja) * 2001-04-26 2004-08-12 第一製薬株式会社 薬剤排出ポンプ阻害薬
US6689782B2 (en) * 2001-07-16 2004-02-10 Essential Therapeutics, Inc. Fungal efflux pump inhibitors
CN1158270C (zh) * 2001-09-26 2004-07-21 四川大学 具有钙离子拮抗作用的双哌嗪类衍生物
JP2005162726A (ja) * 2003-01-24 2005-06-23 Tanabe Seiyaku Co Ltd ピラゾロピリミジン化合物およびその製法
WO2007016496A2 (en) * 2005-08-02 2007-02-08 Neurogen Corporation Dipiperazinyl ketones and related analogues
KR20080061613A (ko) * 2006-12-28 2008-07-03 (주) 비엔씨바이오팜 2-(메틸티오)피리미딘 유도체, 그 제조방법 및 이를포함하는 항바이러스용 약학적 조성물
CN101070308B (zh) * 2007-06-19 2011-05-04 天津药物研究院 异噁唑啉衍生物及其用途
CN101361741B (zh) * 2008-09-22 2011-07-27 天津药物研究院 异噁唑啉类衍生物抗肿瘤新用途
CN104610160A (zh) * 2013-11-04 2015-05-13 南京大学 含哌嗪环的5-硝基咪唑类衍生物及其制备与在抗菌药物中的应用
EP3867242A1 (en) * 2018-10-15 2021-08-25 Nurix Therapeutics, Inc. Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
CA3160713A1 (en) * 2019-12-04 2021-06-10 Nurix Therapeutics, Inc. Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
CN113527227B (zh) * 2020-04-15 2024-06-21 四川弘远药业有限公司 一种卡利拉嗪的制备方法
TW202222311A (zh) * 2020-08-26 2022-06-16 美商塔維達治療公司 結合熱休克蛋白90(hsp90)之共軛體和彼之調製劑
CN112358466B (zh) * 2020-10-10 2021-10-26 广东省微生物研究所(广东省微生物分析检测中心) 1,2,4-三唑-诺氟沙星杂合体及其制备方法和应用
CN112592339B (zh) * 2020-12-22 2022-06-07 广东省微生物研究所(广东省微生物分析检测中心) 1,3,4-恶二唑-2(3h)-硫酮-诺氟沙星杂合体及其制备方法和应用
WO2023055952A1 (en) * 2021-09-29 2023-04-06 C4 Therapeutics, Inc. Neurotrophic tyrosine receptor kinase (ntrk) degrading compounds

Similar Documents

Publication Publication Date Title
RU2356893C2 (ru) Ингибиторы фосфодиэстеразы 4
JP2021529812A5 (cg-RX-API-DMAC7.html)
RU2008108984A (ru) Терапевтический агент от диабета
JP2011526913A5 (ja) キナゾリン化合物及び同化合物を含む治療薬
JP2010520307A5 (cg-RX-API-DMAC7.html)
JP2004538285A5 (cg-RX-API-DMAC7.html)
FR2840897A1 (fr) Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique
RU2007134380A (ru) Антибактериальные производные пиперидина
JP2005533071A5 (cg-RX-API-DMAC7.html)
TNSN07361A1 (en) 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
RU2004137279A (ru) Производные дифенилазетидинона для лечения нарушений метаболизма липидов
JP2004115534A5 (cg-RX-API-DMAC7.html)
JP2021515004A5 (cg-RX-API-DMAC7.html)
RU2017145930A (ru) МОДУЛЯТОРЫ ROR ГАММА (RORγ)
PT2420491E (pt) Compostos de piperidina 3,5-substituída como inibidores de renina
JP2020507606A5 (cg-RX-API-DMAC7.html)
JP2010536821A5 (cg-RX-API-DMAC7.html)
JP2016516028A5 (cg-RX-API-DMAC7.html)
RU2007147344A (ru) Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний
JP2019529359A5 (cg-RX-API-DMAC7.html)
RU2007147338A (ru) Новые производные 2-азетидинона и их применение в качестве ингибиторов всасывания холестерина для лечения гиперлипидемии
JP2022522890A5 (cg-RX-API-DMAC7.html)
JP2006501248A5 (cg-RX-API-DMAC7.html)
MA26858A1 (fr) Acides ox(adi)azolyl-hydroxamiques utiles comme inhibiteurs de procollagene c-proteinase.
RU2008136763A (ru) Гетероциклические противовирусные соединения